Sorry, you must be a member of the group to do that. Join this group.
Gap between second Covid vaccine dose, precaution jab to continue to be 9 months
The members of the government’s technical expert panel on immunisation are yet to reach a consensus on revising the gap between the second covid vaccine dose and precaution dose.
Serum Institute of India CEO Adar Poonawalla had been advocating for reducing the gap to 6 months for quite some time. (Photo by Sanchit Khanna/ Hindustan Times))Published on Apr 30, 2022 03:30 PM IST
NEW DELHI: It may take longer to revise gap between the second covid vaccine dose and precaution dose as members of the government’s technical expert panel on immunisation are yet to reach a consensus on the matter, according to people familiar with the matter.
“The matter is being discussed but for anything to be decided conclusively, a consensus has to be reached. There are voices in favour but also some that feel the gap is just fine at the moment. The discussion should continue on this in the next meeting,” said a person aware of the matter, requesting not to be named.
Serum Institute of India’s chief executive officer, Adar Poonawalla, had been advocating for reducing the gap to 6 months for quite some time.
Precaution dose was opened under the national Covid immunisation programme on January 10 for the high-risk group, before the government took a stand on expanding it for all adults from April 10.
The Centre clarified that the precaution doses will be homologous, which means that if you have received the Covishield vaccine for your first and second doses, your third dose will also be of Covishield and similarly if your first two doses were of Covaxin, the booster shot will also be the same.
RELATED STORIES
No Covid vaccine booster dose for 18-59 age group in Panchkula amid communication delayTips on diagnostics and precautions to keep your baby healthy amidst pandemicSore throat to runny nose; experts on common Covid symptoms in fully vaccinated peopleOver 5 million Covid vaccine doses given to children in 12-15 age group in Uttar PradeshMalaysia scraps Covid-19 tests, outdoor mask mandate for all incoming vaccinated travellersEXPLAINER: Covid-19 pills must be taken within 5 daysState to ask Centre to reduce 9-month gap for booster doseKarnataka COVID-19 vaccination guidelines as of April 28, 2022: BBMP says…The two vaccines that are the mainstay of national Covid immunisation programme are Covaxin and Covishield. Bharat Biotech developed Covaxin in collaboration with the Indian Council of Medical Research, and Serum Institute of India locally manufactured Oxford-AstraZeneca Covid vaccine under the brand name Covishield.
The government has not yet allowed mixing and matching of precaution dose as several trials are currently going on in the country to know the effect of existing vaccines as boosters.
Also, no fresh registration is required for the precautionary dose as all due beneficiaries are already registered on the Co-Win portal.
Source: Hindustan Times.
